Mechanisms of sterilizing immunity provided by an HIV-1 neutralizing antibody against mucosal infection
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012777 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Elie Richel und 9 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Erlangen, Institute of Clinical and Molecular Virology, Friedrich-Alexander Universität Erlangen-Nürnberg, Germany. Hauptthemen laut MEDLINE: HIV-1, Macaca mulatta, Antibodies, Neutralizing, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Broadly neutralizing antibodies (bnAbs) against HIV-1 have been shown to protect from systemic infection. When employing a novel challenge virus that uses HIV-1 Env for entry into target cells during the first replication cycle, but then switches to SIV Env usage, we demonstrated that bnAbs also prevented mucosal infection of the first cells. However, it remained unclear whether antibody Fc-effector functions contribute to this sterilizing immunity. Therefore, additional challenge viruses were produced that contain SIV Env and graded doses of a fusion-defective trimer of HIV-1 Env, to which the bnAb, PGT121 can bind without interfering with the SIV Env-based cell entry. After administration of either PGT121 or its mutant deficient in Fc-effector functions, rhesus macaques were intrarectally exposed to these challenge viruses and to those using either HIV-1 Env or SIV Env for entry into the first cells. Both antibodies similarly reduced infection events with the challenge virus using HIV-1 Env by a factor close to 200. Incorporating fusion-defective HIV-1 Env trimers into the particles of the challenge viruses at densities observed in primary virus isolates did not reduce SIV Env-mediated infection events. The results indicate that the sparsity of bnAb binding-sites on HIV-1 virions limits the contribution of Fc-effector functions to provide sterilizing immunity against mucosal viral infection. Hence, harnessing Fc-effector functions for sterilizing immunity against mucosal HIV-1 infection may require strategies to increase the degree of antibody opsonization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University Hospital Erlangen, Institute of Clinical and Molecular Virology, Friedrich-Alexander Universität Erlangen-Nürnberg, Germany.
- German Primate Center, Göttingen, Germany.
ORCID-Profile: Klaus Überla
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Richel, E., Cordsmeier, A., Bauer, L., Fraedrich, K., Vestweber, R., Roshani, B., Stolte-Leeb, N., Ensser, A., Stahl-Hennig, C., & Überla, K. (2024). Mechanisms of sterilizing immunity provided by an HIV-1 neutralizing antibody against mucosal infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012777
Vancouver
Richel E, Cordsmeier A, Bauer L, Fraedrich K, Vestweber R, Roshani B, et al. Mechanisms of sterilizing immunity provided by an HIV-1 neutralizing antibody against mucosal infection. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012777
BibTeX
@article{Richel2024,
author = {Richel, Elie and Cordsmeier, Arne and Bauer, Larissa and Fraedrich, Kirsten and Vestweber, Ramona and Roshani, Berit and Stolte-Leeb, Nicole and Ensser, Armin and Stahl-Hennig, Christiane and Überla, Klaus},
title = {Mechanisms of sterilizing immunity provided by an HIV-1 neutralizing antibody against mucosal infection},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012777}
}
EUVIMED